Emergent BioSolutions shares rally as Narcan gets over-the-counter OK from FDA


Emergent Biosolutions Inc.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The firm’s products include ACAM2000, BioThrax, Raxibacuma, Vaxchora, and VIGIV. Its business units include Vaccines and Anti-Infectives, Antibody Therapeutics, Devices, and Contract Development and Manufacturing. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

This article was originally published by Marketwatch.com. Read the original article here.

Previous article: Warner Music Group to cut around 4% of its overall workforce
Next article: Fiery French protests and widespread Israeli strike reflect discord with democracy. The U.S. is not immune.


Please enter your comment!
Please enter your name here